Small molecule · Antagonist of Histamine H1 receptor (HRH1) · developed by Chattem Sanofi
ApprovedFDA, Jan 2011
1Registered trials
What is Fexofenadine?
Fexofenadine is a second-generation selective histamine H1 receptor antagonist that competitively and reversibly blocks peripheral H1 receptors in the gastrointestinal tract, blood vessels and bronchial smooth muscle. It also interferes with mast cell mediator release. It is studied in drug interaction research, and is used for allergic conditions such as hives and hay fever.
Summary written with AI from the sources listed at the end of this page.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.